article thumbnail

Cybersecurity in pharma: Securing the future

Pharmaceutical Technology

Cybersecurity challenges As per a Healthcare Information and Management Systems Society (HIMSS) 2022 survey, there is a need for greater awareness on Health Insurance Portability and Accountability Act (HIPAA) and data privacy along with other measures. Cybersecurity is necessary for biosecurity.”

HIPAA 110
article thumbnail

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of third-party cookies, which all marketers must consider. Premium Placement Quality Allows Creative to Shine.

HIPAA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Toni R. Hofhine, President of ATCOR Medical (CardieX) Shares Insights from Pulse- a New at-home Heart Health Monitor

PharmaShots

The device is used for remote patient monitoring, home health, and clinical trials She also elaborated about the data used for the pre-marketing submission with FDA. Smriti: Can we discuss the data being used for the premarket submission with FDA? 

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3.

article thumbnail

Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies

pharmaphorum

Both the EMA and FDA have released draft guidance on the issue and are currently soliciting feedback. Therefore, vendor applications must adhere to HIPAA and GDPR data protection regulations, including encryption and multifactor authentication.

article thumbnail

He Slimed Me: FTC Hits GoodRx Over Unauthorized Use of Consumer Data

The FDA Law Blog

GoodRx is alleged to have shared ostensibly protected personal health information with other tech companies, used the data for ad targeting, allowed third-party use of the data, used a HIPAA seal on its site that misrepresented its compliance status, and failed to put other policies in place to protect the data.

FDA 105
article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

In December 2021, the US FDA issued a cross-center draft guidance with recommendations on the use of digital health technology tools (DHTTs) to acquire data remotely from participants in clinical investigations for medical products. Table 3: Example classification of DHTs. .